ClinicalTrials.Veeva

Menu

the Impact of Occupational Therapy : a Multicenter Randomized Controlled Trial (OCEAN-OT)

A

Assistance Publique - Hôpitaux de Paris

Status

Not yet enrolling

Conditions

Elderly Patient
Quality of Life
Cancer

Treatments

Other: MCRO+Occupational therapy
Other: MCRO without intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT05878782
APHP230405

Details and patient eligibility

About

The purpose of this randomized controlled superiority trial is to evaluate the impact of occupational therapy assessment and intervention on the quality of life of elderly cancer patients.

Patients will be randomized into 3 parallel, multicenter arms with patient-reported outcome and blinded evaluator.

  • Experimental group A will combine the assessment of occupational problems (MCRO) and an occupational therapy intervention.
  • Experimental group B will have only the MCRO assessment because the occupational problems assessment alone (without intervention) could improve quality of life and occupational performance outcomes, according to the Nielsen, 2019 study
  • Group C will have the usual cancer management care combining specific treatments and supportive care.

Full description

in order to limit the potential grading bias associated with the open-label design, the reassessment at 3 and 6 months will be performed by a different occupational therapist than the one who performed the initial assessment and occupational therapy intervention. For this reason, at least two occupational therapists per geographic area of the centers that include the patients will be included in the project.

Enrollment

232 estimated patients

Sex

All

Ages

70+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥ 70 years;
  • Colorectal, breast, prostate or lung cancer;
  • Between 1 and 3 months after the start of cancer treatment depending on the type of treatment (Surgery and/or systemic treatment and/or radiotherapy);
  • For curative purposes;
  • Affiliated to a social security scheme;
  • Living at home;
  • Agreeing to participate in the research and having given a free, informed and signed consent

Exclusion criteria

  • person caring for a patient meeting the above criteria;
  • Living with the patient;
  • Agreeing to participate in the research and having given free, informed and signed consent

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

232 participants in 3 patient groups

Occupational therapy intervention associated with MCRO assesment.
Experimental group
Description:
the experimental care of this group will combine the assessment of occupational problems (MCRO) and an occupational therapy intervention.
Treatment:
Other: MCRO+Occupational therapy
MCRO assessment without intervention
Experimental group
Description:
This experimental group will have only the MCRO assessment because the occupational problems assessment alone (without intervention) could improve quality of life and occupational performance outcomes, according to the Nielsen, 2019 study
Treatment:
Other: MCRO without intervention
Usual care
No Intervention group
Description:
this group will have the usual cancer management care combining specific treatments and supportive care.

Trial contacts and locations

0

Loading...

Central trial contact

France Guyot; Cynthia Engels, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems